IL-11 is required for A1 adenosine receptor-mediated protection against ischemic AKI

Joo Yun Kim, Mihwa Kim, Ahrom Ham, Kevin M. Brown, Robert W. Greene, Vivette D. D'Agati, H. Thomas Lee

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


A1 adenosine receptor activation ameliorates ischemic AKI through the induction of renal proximal tubular sphingosine kinase-1. However, systemic adverse effects may limit A1 adenosine receptor-based therapy for ischemic AKI, indicating a need to identify alternative therapeutic targetswithin this pathway. Here, we evaluated the function of renal proximal tubular IL-11, a clinically approved hematopoietic cytokine, in A1 adenosine receptor-mediated induction of sphingosine kinase-1 and renal protection. Treatment of human proximal tubule epithelial (HK-2) cells with a selective A1 adenosine receptor agonist, chloro-N(6)- cyclopentyladenosine (CCPA), induced the expression of IL-11 mRNA and protein in an extracellular signal-regulated kinase-dependent manner, and administration of CCPA in mice induced renal synthesis of IL-11. Pretreatment with CCPA protected against renal ischemia-reperfusion injury in wild-type mice, but not in IL-11 receptor-deficient mice. Administration of an IL-11-neutralizing antibody abolished the renal protection provided by CCPA. Similarly, CCPAdid not induce renal IL-11 expression or protect against renal ischemia-reperfusion injury in mice lacking the renal proximal tubular A1 adenosine receptor. Finally, treatment with CCPA induced sphingosine kinase-1 in HK-2 cells and wild-type mice, but not in IL-11 receptor-deficient or renal proximal tubule A1 adenosine receptor-deficient mice. Taken together, these results suggest that induction of renal proximal tubule IL-11 is a critical intermediary in A1 adenosine receptor-mediated renal protection that warrants investigation as a novel therapeutic target for the treatment of ischemic AKI.

Original languageEnglish (US)
Pages (from-to)1558-1570
Number of pages13
JournalJournal of the American Society of Nephrology
Issue number10
StatePublished - Oct 2013

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'IL-11 is required for A<sub>1</sub> adenosine receptor-mediated protection against ischemic AKI'. Together they form a unique fingerprint.

Cite this